Syros Pharmaceuticals, Inc.

The momentum for this stock is not very good. Syros Pharmaceuticals, Inc. is not a good value stock. Syros Pharmaceuticals, Inc. is not a good growth stock. Syros Pharmaceuticals, Inc. is not very popular among insiders. Syros Pharmaceuticals, Inc. is a mediocre stock to choose.
Log in to see more information.
Syros Pharmaceuticals, Inc. engages in the development of novel gene control therapies for cancer an...
SYRS Fundamental Data by TradingView

News

Certuity LLC Invests $109,000 in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)
Certuity LLC Invests $109,000 in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)

Zolmax Certuity LLC acquired a new position in shares of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The...\n more…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS

PR Newswire SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...\n more…

Syros Pharmaceuticals (NASDAQ:SYRS) Share Price Crosses Below 50-Day Moving Average of $4.20
Syros Pharmaceuticals (NASDAQ:SYRS) Share Price Crosses Below 50-Day Moving Average of $4.20

Ticker Report Syros Pharmaceuticals, Inc. (NASDAQ:SYRS - Get Free Report) shares passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $4.20 and traded as low...\n more…

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings

Globe Newswire NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Syros Pharmaceuticals, Inc...\n more…

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings

Business Wire Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Syros Pharmaceuticals, Inc. (Syros or the Company) (NASDAQ: SYRS). Investors who...\n more…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS

PR Newswire SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...\n more…